New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 19, 2012
16:33 EDTEBAY, TUMI, TRV, GILD, GSK, SPLK, VZ, GNTX, HGSI, DD, BACOn The Fly: Closing Wrap
Stocks on Wall Street were lower, as disappointing economic data overshadowed earnings that were largely better than expected. Stock futures were higher in early trading but weakened following disappointing jobless claims data and a rumor the sovereign debt of France would lose its AAA rating. When the French rumor went unfounded the market moved higher, but just temporarily. The averages stalled again after existing home sales data for March showed a decline versus an expected increase but gathered once more to move back into positive territory. As the day progressed and the European markets closed lower, the averages lost any momentum they'd found and fell back into negative ground. For the remainder of the day the market drifted in the red as investors prepared for the next round of corporate earnings reports... ECONOMIC EVENTS: In the U.S., more jobless claims applications were filed than forecast, with the figure hitting 386,000. Sales of previously owned homes in March unexpectedly fell 2.6% to a 4.48M annual rate from 4.6M in February. Forecasts had called for an increase to 4.61M. In Europe, Spain was able to sell more bonds than expected but at higher yields, leaving mixed impressions among investors... COMPANY NEWS: Bank of America (BAC) posted Q1 adjusted results that beat consensus, but shares declined 1.68% to $8.77. Among other Dow components, Verizon (VZ) and Travelers (TRV) also reported earnings that exceeded expectations and both saw their shares rise following the reports, with Verizon gaining 1.30% to $38.15 and Travellers advancing 3.75% to $61.70. Du Pont (DD) was the fourth Dow name to beat on earnings, but shares fell 1.24% to $52.61... Meanwhile, data analysis software company Splunk (SPLK) and luxury luggage and briefcase maker Tumi Holdings (TUMI) both surged after debuting their IPOs on the Nasdaq. Splunk shares priced at $17 and ended the day at $35.48, while Tumi priced at $18 and closed at $26.50… MAJOR MOVERS: Among the notable gainers were Human Genome Sciences (HGSI), up $7, or 97.63%, to $14.17, after saying it had turned down an unsolicited $13 per share, or approximately $2.6B, buyout proposal from GlaxoSmithKline (GSK), and eBay (EBAY), up $4.75, or 13.24%, to $40.62, as the company’s sales and profits beat analyst estimates, led by growth in its PayPal online payments business. Noteworthy losers included Gentex (GNTX), down $4.07, or 16.01%, to $21.35, after its top-line miss continued to reinforce investor fears over slowing growth, and Achillion (ACHN), down $1.20, or 12.63%, to $8.30, with the decline attributed by Wells Fargo to positive data for Gilead's (GILD) oral hepatitis C combination treatment… INDICES: The Dow lost $68.65, or 0.53%, to 12,964.10; the Nasdaq fell $23.89, or 0.79%, to 3,007.56; and the S&P 500 dropped $8.22, or 0.59%, to 1,376.92.
News For BAC;VZ;TRV;DD;SPLK;TUMI;HGSI;GSK;EBAY;GNTX;GILD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
May 12, 2015
07:09 EDTVZAOL CEO says will 'certainly' buy Verizon stock
Subscribe for More Information
07:08 EDTVZAOL CEO says company has 'shared vision' with Verizon
Subscribe for More Information
07:06 EDTVZAOL volatility elevated into Verizon acquiring for $4.4B
Subscribe for More Information
07:03 EDTVZVerizon to acquire AOL for $50 per share, an estimated total value of $4.4B
Subscribe for More Information
07:01 EDTVZVerizon to acquire AOL for $50 per share, an estimated total value of $4.4B
Subscribe for More Information
07:01 EDTVZVerizon to acquire AOL for $50 per share, or $4.4B
Subscribe for More Information
06:40 EDTVZVerizon downgraded to Underperform from Neutral at Macquarie
Macquarie downgraded Verizon to Underperform with a $45 price target to reflect a weaker 2016 and 2017 earnings outlook. The firm's analyst believes management has made a series of questionable strategic moves beginning with the Vodafone deal that will depress earnings. Recent advertising promotions are likely to pressure 2015 margins and ARPU and LTE capacity issues are expected in certain markets later in the year. Macquarie is surprised Verizon shares have held in around $50 with treasury yields rising and increasing Q2 promotions and does not believe this is sustainable ahead of a reset in consensus estimates.
06:02 EDTGSKGSK CEO cites 'poor choices' in rivals' M&A deals, Financial Times reports
Subscribe for More Information
05:26 EDTDDDuPont issues statement regarding Trian's statements
Subscribe for More Information
May 11, 2015
16:00 EDTBACOptions Update; May 11, 2015
Subscribe for More Information
15:54 EDTGSKGlaxo CEO defends strategy, warns of risks of chasing higher prices, FT says
GlaxoSmithKline (GSK) CEO Andrew Witty defends the company's shift in focus from high-priced prescription drugs to higher volume, but lower priced, products, warning that chasing ever-higher prices risks undermining the industry and may create "its own tension that leads to some kind of change,” reported Financial Times, citing an interview. Witty acknowledges the company's asset swap with Novartis (NVS) opens the door to a potential break up, but argues there are benefits to keeping pharmaceuticals, vaccines and consumer goods together and there would be “no logic” in a split at this early time after the Novartis deal, the report added. Reference Link
14:24 EDTVZFrontier announces HSR clearance for acquisition of certain Verizon assets
Subscribe for More Information
12:28 EDTDDPeltz says 'we don't even think of not winning' DuPont proxy contest
Subscribe for More Information
12:24 EDTDDPeltz says chances for last minute deal with DuPont 'dim'
Nelson Peltz says he wants to be collaborative with DuPont, adding that he is restricted in his comments about DuPont due to legal reasons as his proxy fight with the company continues. Peltz, however, said the prospects for a last minute settlement with DuPont are "very dim" and that his last talks with DuPont were weeks ago. Peltz said he and Trian are committed to maintaining R&D levels at DuPont. Nelson Peltz of Trian Fund Management is speaking on CNBC.
11:32 EDTDDDuPont indicates support from CalPERS, others for board nominees
Subscribe for More Information
09:58 EDTBACBarclays expected to pay GBP2B to settle forex rigging charges, FT says
Subscribe for More Information
09:37 EDTBACActive equity options trading on open
Subscribe for More Information
08:18 EDTBACBanks executives seek to push back on 'false, damaging' statements, WSJ reports
Subscribe for More Information
06:05 EDTVZSpherix issued standard-essential patent by USPTO
Spherix (SPEX) announced that the United States Patent & Trademark Office, or USPTO, is issuing the company another standard-essential patent. The company has received from the USPTO an issue notification for patent RE45521, set to issue on May 19. This patent is part of the same family of standard-essential patents currently being litigated against both Cisco (CSCO) and Verizon (VZ). The patented technology relates to the transmittal of data over a network and further enhances the company's existing portfolio.
05:58 EDTGSKUNC, GlaxoSmithKline create dedicated HIV Cure center
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use